NCAPD2 and melanoma: NCAPD2 showed good predictive ability (AUC > 0.7) in HNSC and melanoma, MSI showed good predictive ability (AUC > 0.7) in melanoma and gastric cancer, and TMB had good predictive ability (AUC > 0.7) in urothelial cancer.